
<?xml version='1.0' encoding='UTF-8'?>
<article>
<front>
<journal-meta>
<journal-id journal-id-type='publisher'>IJRAP</journal-id>
<journal-title>International Journal of Research in Ayurveda and Pharmacy</journal-title>
<issn pub-type='ppub'>2277-4343</issn>
 <publisher>
<publisher-name>Moksha Publishing House </publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type='other'>10.7897/2277-4343.175186</article-id>
<title-group>
<article-title>A REVIEW ON MEDICINAL PLANTS AS EMERGING ANTI-UROLITHIATIC AGENTS: RECENT ADVANCES IN PHYTOPHARMACOLOGY, EXPERIMENTAL EVIDENCE, MOLECULAR MECHANISMS, AND FUTURE CLINICAL PERSPECTIVES
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type='author'>
<name>Santhosh *</name>
</contrib>
<contrib contrib-type='author'>
<name> Mohamed Fiaz A</name>
</contrib>
<contrib contrib-type='author'>
<name> Srinivasan P</name>
</contrib>
<contrib contrib-type='author'>
<name> Suhel Y</name>
</contrib>
<contrib contrib-type='author'>
<name> Dhachinamoorthi D</name>
</contrib>
</contrib-group>
<pub-date>
<month>11</month>
<year>-0001</year>
</pub-date>
<fpage>146</fpage>
<lpage>156</lpage>
<abstract><title>Abstract</title>
Urolithiasis is a common urinary tract disorder characterised by the formation and retention of crystalline calculi in the urinary system. Medicinal plants have attracted increasing interest as potential anti-urolithiatic agents because they may act through multiple complementary mechanisms, including inhibition of calcium oxalate crystallisation, enhancement of diuresis, reduction of urinary supersaturation, antioxidant activity, anti-inflammatory effects, nephroprotection, and promotion of crystal elimination. This review summarises recent evidence on medicinal plants with anti-urolithiatic potential, with emphasis on experimental findings reported between 2020 and 2026. We consider evidence from in vitro, in vivo, clinical, and computational investigations, including studies on crystal nucleation, growth, and aggregation assays; animal models of urolithiasis; molecular docking; network pharmacology; molecular dynamics; and ADMET prediction. The review also discusses key phytoconstituents, molecular pathways, and emerging therapeutic targets associated with preventing renal crystal formation and tissue injury. Current evidence supports the pharmacological potential of several medicinal plants; however, variability in phytochemical composition, inadequate extract standardisation, limited pharmacokinetic characterisation, and a shortage of well-designed clinical trials limit translation into clinical practice. Future research should prioritise standardised preparations, mechanistic validation, pharmacokinetic and toxicological evaluation, and adequately powered clinical studies to establish the safety, efficacy, and therapeutic role of plant-derived anti-urolithiatic interventions.
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Urolithiasis</kwd>
<kwd> Medicinal plants</kwd>
<kwd> Phytopharmacology</kwd>
<kwd> Calcium oxalate</kwd>
<kwd> Nephrolithiasis</kwd>
<kwd> Antioxidant</kwd>
<kwd> Nephroprotection.</kwd>
</kwd-group>
<counts><ref-count count='0'/><page-count count='6'/></counts>
</article-meta></front><back><ref-list><title>References</title></ref-list></back></article>
